Trial Profile
Phase II Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2018
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine H5N2 (Primary)
- Indications Influenza A virus infections
- Focus Adverse reactions; Pharmacodynamics
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 May 2013 New trial record